CAR-T Safe in Myeloma Patients With Autoimmune Diseases, Small Study Finds

(MedPage Today) -- A retrospective study presented at the recent American Society of Clinical Oncology (ASCO) meeting suggested that patients with autoimmune diseases may safely receive idecabtagene vicleucel (ide-cel; Abecma) for relapsed or refractory...